AUTOANTIBODIES AND SYSTEMIC SCLEROSIS

NCT06502678 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Understand Pathogenicity of SSc-specific Antibodies in SSc and the Effect of Antibody Blockade in Vitro

Interventions

BIOLOGICAL: Fcr blocker of autoantibodies

Sponsor

IRCCS Ospedale San Raffaele